The investigators assessed the utility of ultrasonography in confirming the position of nasal jejunal tube after bedside placement when compared with endoscopic placement in patients with severe acute pancreatitis. Primary endpoint: Success rate. Secondary Endpoint: Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after placement), Tolerance of enteral nutrition, Time to approach the target calories.
We set this randomised trial to assess the safety and utility of ultrasonography in confirming the position of nasal jejunal tube after bedside placement when compared with endoscopic placement in patients with severe acute pancreatitis. Primary endpoint: Success rate. Secondary Endpoint: Adverse effects, Change of intra-abdominal pressure (1h before, 1h after and 3 days after placement), Tolerance of enteral nutrition, Time to approach the target calories.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
bedside placing nasal jejunal tube with ultrasound confirmation versus placing endoscopically
JinLing hospital
Nanjing, Jiangsu, China
RECRUITINGSuccess rate
Success rate is defined as the right position of nasal jejunal tube confirmed by X-ray.
Time frame: 24 hours
Adverse effects
gastrointestinal perforation, gastrointestinal bleeding, tie of the tube, blocking of the tube
Time frame: 24 hours
Change of intra-abdominal pressure
the intra-abdominal pressure at 1h before, 1h after and 3 days after placement
Time frame: 3 days
Tolerance of enteral nutrition
nausea, vomiting, diarrhea, abdominal pain
Time frame: 3 days
Time interval to approach the target calories
The exact time interval from the placement of the tube to the time that the patient can tolerate the target enteral nutrition.
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.